Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1903 of 6351
-
New hope for indian men with aggressive prostate cancer: darolutamide trial launches
Disease control Recruiting nowResearchers are looking for a better way to treat men who have non-metastatic castration-resistant prostate cancer (nmCRPC). This is a type of cancer of the prostate that has not yet spread to other parts of the body and that keeps progressing even when the amount of male sex hor…
Phase 4 • Sponsor: Bayer • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
New pill shows promise for tough stomach cancer in early trial
Disease control OngoingThis is the first clinical trial of IDRX-42. The study is designed to evaluate the safety, tolerability, PK, and preliminary antitumor activity of IDRX-42 in adult participants with advanced (metastatic and/or surgically unresectable) GIST.
Phase 1 • Sponsor: IDRX, Inc., a wholly owned subsidiary of GSK, LLC • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
New drug cocktail targets Hard-to-Treat amyloidosis
Disease control OngoingThis phase I/Ia trial finds the best dose and side effects of venetoclax given in combination with ixazomib citrate and dexamethasone in treating patients with light chain amyloidosis that has come back (relapsed) or does not respond to treatment (refractory) and who have an abno…
Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
New eyedrop shows promise for Mite-Related dry eye
Disease control CompletedThe purpose of this study is to compare the safety and efficacy of TP-03, 0.25%, an eyedrop, BID vs TID dosing regimens for the treatment of meibomian gland dysfunction in patients with Demodex lid infestation.
Phase 2 • Sponsor: Tarsus Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Experimental drug shows promise for stiff heart disease
Disease control CompletedThis study is testing a potential new medicine, NNC6019-0001, for people who have a heart disease due to TTR amyloidosis.The study will look at if this medicine can reduce the symptoms of a heart disease due to TTR amyloidosis, such as heart failure. Participants will either get …
Phase 2 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Could this pill ease Meniere's hearing loss and dizziness?
Disease control CompletedThe study is a randomized, double-blind, placebo-controlled, multi-center clinical trial (RCT) with open-label extension study (OLE), of SPI-1005 in adult subjects with definite Meniere's disease with active symptoms within three months preceding study enrollment.
Phase 3 • Sponsor: Sound Pharmaceuticals, Incorporated • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
Massive global registry aims to unlock secrets of rett syndrome
Knowledge-focused Recruiting nowThe Rett Syndrome Registry is a longitudinal observational study of individuals with MECP2 mutations and a diagnosis of Rett syndrome. Designed together with the IRSF Rett Syndrome Center of Excellence Network medical directors, this study collects data on the signs and symptoms …
Sponsor: International Rett Syndrome Foundation • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
Experimental drug combo takes on tough cancers
Disease control CompletedThe primary purpose of this study is to characterize the safety profile of BMS-986408 as monotherapy and in combination with nivolumab or nivolumab and ipilimumab to establish the maximum tolerated dose (MTD). The Recommended Phase 2 Dose (RP2D) that optimizes the pharmacokinetic…
Phase 1/2 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
Virtual reality offers new hope for facial paralysis sufferers
Symptom relief Recruiting nowPeripheral facial palsy affects 15 to 40 people per 100,000 inhabitants and induces important functional and social repercussions. Synkinesis is a frequent after-effect of facial palsy recovery, consisting of involuntary facial spasms that disturb the gestural harmony and can go …
Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Gut bacteria transplant shows promise for recurring UTIs
Disease control Completedhis is a single-center, prospective, single-arm, interventional clinical study to evaluate the clinical efficacy, safety, and potential mechanisms of washed microbiota transplantation (WMT) in patients with recurrent urinary tract infections (rUTI). Recurrent UTI is defined as ≥2…
Phase 1/2 • Sponsor: The Second Hospital of Nanjing Medical University • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Could your diet boost your chance of having a baby?
Knowledge-focused Recruiting nowWorldwide infertility is highly prevalent and lifestyle factors, such as food intake, could have an essential role in the success of a fertility treatment. The literature is not consistent and adequate for recommendations to the increasing number of women and men of reproductive …
Sponsor: Aalborg University Hospital • Aim: Knowledge-focused
Last updated Jul 10, 2026 00:00 UTC
-
A $75 nudge: can social transfers boost exclusive breastfeeding?
Prevention CompletedThe goal of this study is to assess the effectiveness of social transfers on exclusive breastfeeding rates in Lao PDR. The main questions it aims to answer are: 1. Are social transfers effective at increasing exclusive breastfeeding rates at 6-months 2. Are social transfers cost…
Sponsor: Swiss Tropical & Public Health Institute • Aim: Prevention
Last updated Aug 21, 2026 00:00 UTC
-
Ear device zaps nerves to tame stubborn high blood pressure?
Disease control CompletedThis is a pilot, sham-controlled, double blind, single-site device clinical trial designed to evaluate the safety, acceptability and efficacy of non-invasive autonomic neuromodulation in a cohort of 63 adult patients with uncontrolled high blood pressure.
Sponsor: Queen Mary University of London • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
New diabetes drug shows promise for early treatment
Disease control OngoingThis study aims to investigate the efficacy and safety of tirzepatide in participants with type 2 diabetes (T2D) compared to other existing treatment options when treatment is initiated early.
Phase 4 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Can a neck injection quiet the Brain's fear response in PTSD?
Symptom relief OngoingThis study will enroll patients meeting Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) criteria for post-traumatic stress disorder (PTSD). Following an initial screening visit, clinical assessment, and enrollment, subjects will be randomized into tre…
Phase 4 • Sponsor: NYU Langone Health • Aim: Symptom relief
Last updated Jun 27, 2026 12:05 UTC
-
Tailored magnetic pulses aim to restore pleasure in depressed patients
Symptom relief CompletedThis program of research constitutes a three-arm, randomized, placebo-controlled trial testing noninvasive brain stimulation for the treatment of anhedonic depression. This trial is part of a larger, three-site study that will be conducted at UCSD, Stanford University, and Cornel…
Sponsor: University of California, San Diego • Aim: Symptom relief
Last updated Jun 27, 2026 09:05 UTC
-
Fasting during chemo: a new weapon against breast cancer?
Disease control CompletedThis randomized controlled trial investigates the effects of intermittent fasting and water-only fasting on gene expression, tumor markers, quality of life, and chemotherapy tolerance in breast cancer patients receiving chemotherapy. Breast cancer remains the most commonly diagno…
Sponsor: Khyber Medical University Peshawar • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
New hope for tough colorectal cancer: LYL273 trial opens
Disease control Recruiting nowThis is a Phase 1/2 open-label, multicenter study evaluating the safety and efficacy of LYL273 in participants with relapsed or refractory metastatic colorectal cancer.
Phase 1/2 • Sponsor: Lyell Immunopharma, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Shock without surgery: new device aims to ease back pain
Symptom relief Recruiting nowAs a leading cause of disability worldwide, chronic low back pain (cLBP) represents a significant medical and socioeconomic problem with estimated health care spending of $87 billion/annually. The efficacy of dorsal column electrical stimulation to inhibit pain was first describe…
Sponsor: University of California, San Francisco • Aim: Symptom relief
Last updated Jun 27, 2026 09:11 UTC
-
Urine test may spot hidden thyroid cancer, avoid unnecessary surgery
Diagnosis OngoingThyroid cancer is the most common endocrine malignancy in the world. Generally, thyroid cancer could be divided into well-differentiated and poorly-differentiated. Well-differentiated thyroid cancers usually have two different patterns, including papillary thyroid cancer and foll…
Sponsor: National Taiwan University Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 12:06 UTC